APG Pharma Coming Soon!

Our product pipeline is strategically focused on licensing a range of General Sales List (GSL) medicines that are currently underserved in the market. We are identifying products that align with unmet needs among our customers, with the goal of improving access to everyday healthcare solutions. As our business continues to grow at pace, we are actively evaluating new licensing opportunities to support our ambitious expansion plans. 

We anticipate launching our first GSL medicines by Q4 2025. 

In addition to our licensed medicines, we offer a complementary range of general healthcare products designed to support consumer wellbeing and round out our portfolio with high-quality, trusted solutions.